|
|
|
|
Cephalon Exercises its Option to Acquire Ception Therapeutics
Cephalon, Inc.announced today that it has exercised its option to acquire Ception Therapeutics, Inc., following receipt of positive data from a clinical study in adults with eosinophilic asthma. A Phase II clinical trial of Ception's lead compound, CINQUIL...
|
|
|
Doctor Pleads Guilty to Research Fraud Involving Vioxx and Celebrex
RODRIQUE NGOWI Associated Press Writer BOSTON (AP) ' A doctor accused of faking research for a dozen years in published studies that suggested after-surgery benefits from painkillers including Vioxx and Celebrex pleaded guilty Monday to one count of federal...
|
|
|
FDA Announces Possible Safety Concern for HIV Drug Combination
The FDA today announced preliminary data suggesting that Invirase (saquinavir) in combination with Norvir (ritonavir) may have potentially important adverse effects on the heart.When used together, the drugs may cause prolongation of the QT and PR intervals...
|
|
|
FDA Panel Backs Salix Drug for Brain Damage
WASHINGTON (AP) ' Federal health experts are recommending Salix Pharmaceutical's drug Xifaxan be approved to treat brain damage caused by liver failure.The Food and Drug Administration's gastrointestinal drugs panel voted 14 to 4 that the drug's benefits...
|
|
|
Forest Laboratories Receives Decision from FDA for Supplemental New Drug Application for Bystolic
(Forest Laboratories, Inc.announced today that the FDA did not approve the additional indication for Bystolic(R) (nebivolol) tablets as a treatment for stable chronic heart failure (CHF) as requested in the company's Supplemental New Drug Application (sNDA)....
|
|
|
Lilly, Merck, And Pfizer Join Forces To Accelerate Research And Improve Treatment Of Lung And Gastric Cancers
Eli Lilly and Company, Merck (also known as Merck Sharp & Dohme (MSD) outside the USA and Canada), and Pfizer Inc.today announced the formation of the Asian Cancer Research Group, Inc., (ACRG), an independent, not-for-profit company established to...
|
|
|
Merck Makes 4th quarter Net Profit of $78 million
GEORGE FREY AP Business Writer FRANKFURT (AP) ' Merck KGaA said Tuesday it made a net profit in the fourth quarter, compared with a loss a year ago, as revenue rose sharply, but shares in the company slumped on a weak outlook and lowered dividend.Merck,...
|
|
|
Roche's Phase III Avastin Study Misses Primary Endpoint
Roche announced today the topline results from a global phase III trial investigating the use of Avastin (bevacizumab) in combination with Xeloda (capecitabine) or fluorouracil and cisplatin chemotherapy in patients with inoperable, advanced or metastatic...
|
|
|
Transcept Pharmaceuticals Provides Update on Intermezzo(R) Regulatory Review
Transcept Pharmaceuticals, Inc.has announced today an update on its plans to seek FDA approval of Intermezzo (zolpidem tartrate sublingual tablet) for use as-needed for the treatment of insomnia when a middle of the night awakening is followed by difficulty...
|
|
|
Watson, Biovail in Lawsuit Over Depression Drug
CORONA, Calif.(AP) ' Watson Pharmaceuticals said Monday that it is being sued by Biovail Corp. after it sought federal approval for a generic version of that company's anti-depression drug. Biovail filed suit in U.S. District Court for the District of...
|
